Table 1.
Baseline patient characteristics.
| Variable | n = 125 |
|---|---|
| Age (years, range) | 74.3 ± 8.86 (41–88) |
| Gender (Male vs. Female) | 96/29 |
| Child-Pugh score (score of 5 vs. score of 6) | 69/56 |
| Etiology (HBV vs. HCV vs. non-B non-C) | 12/64/49 |
| Treatment history (Naïve vs. recurrence) | 30/95 |
| Up-to-seven criteria (within vs. beyond) | 68/57 |
| Tumor number | 4.47 ± 3.67 |
| Maximum tumor size (cm) | 4.86 ± 9.45 |
| Number of TACE procedures | 1.95 ± 1.23 |
| AST (IU/L) | 47.8 ± 30.5 |
| ALT (IU/L) | 35.1 ± 30.3 |
| Platelets (×104/μL) | 14.8 ± 9.92 |
| ALB (g/dL) | 3.68 ± 0.43 |
| T-Bil (mg/dL) | 0.82 ± 0.31 |
| PT (%) | 90.5 ± 14.8 |
| AFP (ng/mL) | 3506 ± 14194 |
| DCP (mAU/mL) | 2900 ± 9532 |
| FIB-4 index | 5.59 ± 4.00 |
| M2BPGi (cut-off index) | 3.31 ± 3.01 |
Values are presented as mean ± standard deviation (range) or number. Abbreviations: HBV, hepatitis B virus; HCV, hepatitis C virus; TACE, transarterial chemoembolization; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALB, albumin; T-Bil, total bilirubin; PT, prothrombin time; AFP, α–fetoprotein; DCP, des-γ-carboxy prothrombin; FIB-4, Fibrosis-4; M2BPGi, Mac-2-binding protein glycosylation isomer.